Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botox for Chronic Cluster Headache (BASIC)
NCT03944876Phase 3Recruiting
- Sponsor
- Norwegian University of Science and Technology
- Start
- Nov 2019
- Primary completion
- Sep 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 5
01
Overview
Phase 3, randomised, triple-blind trial in Cluster Headache (CH) comparing Botox Arm with Placebo Arm (2 arms). Primary endpoint: Change from baseline in mean number of cluster headache attacks per week at weeks 5-8. Started Nov 2019; status: recruiting.
02
Drugs
botulinum toxin type A
03
Conditions
Cluster Headache (CH)
Beyond the preview
Go deeper on NCT03944876.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03944876.